How does a hospital’s participation in a health plan’s Medicare Advantage (MA) provider network impact their commercial rates? Since many insurers offer both MA plans and commercial plans, there could be spillovers with respect to negotiating. How would MA network participation impact commercial rates? Marr et al. (2025) offers some hypotheses: On the one hand,…
Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and Pensions Committee on Wednesday. He faced questions on vaccines, HHS cuts and other issues. The post Congress Scrutinizes RFK Jr. on Budget Cuts, Vaccines and More appeared first on MedCity News.
Cohere Health raked in $90 million in Series C capital, taking its total funding to date to $200 million. This round of funding cements Cohere as the emerging winner in the prior authorization tech category, according to Michael Greeley, general partner at Flare Capital Partners. The post Cohere Health Snags $90M to Automate the Much-Maligned…
Robert F. Kennedy Jr. testified before the Senate Committee on Health, Education, Labor and Pensions on Wednesday about President Donald Trump’s fiscal 2026 Department of Health and Human Services budget request. That followed a morning hearing with the House Appropriations Committee. The sessions were the first time Kennedy appeared before Congress following the mass layoffs…
It has been nearly eight years since Sen. John McCain’s middle-of-the-night thumbs-down vote torpedoed Republican efforts to repeal the Affordable Care Act and make drastic cuts to Medicaid. With Donald Trump back in the White House and the GOP back in control of Congress, Republicans again have their eyes on Medicaid, the government health program…
GSK is acquiring Boston Pharmaceuticals’ efimosfermin, which posted Phase 2 results showing improvement in fibrosis and resolution of MASH. GSK said this fusion protein will complement an siRNA drug it is currently developing for liver diseases. The post GSK Makes a Big Liver Disease Move With $1.2B Deal for Phase 3-Ready MASH Drug appeared first…
Medicaid is the main source of coverage for adults with opioid use disorder and among those receiving treatment services. Most adults with OUD in Medicaid are eligible through Medicaid expansion.
The real change with AI will happen not when everyone adopts the technology, which is happening quickly, but when these AIs can actually communicate and coordinate with one another. The post The AI Drug Discovery Boom Is Coming. We Are Not Ready. appeared first on MedCity News.
Before health systems can realize more revenue from telemedicine services, they need a technology foundation that enables deeper insights into operations and service expansion. The post Data Integration: The Essential Element in Telemedicine Sustainability appeared first on MedCity News.
Stephen Konya, Chief, Innovation and Strategic Partnerships, ASTP with the Department of Health and Human Services, will speak at INVEST, MedCity’s annual investor conference in Chicago, May 20-21. Register today! The post HHS Health IT Innovation Exec Joins INVEST Agenda at Critical Time for the Department appeared first on MedCity News.